IP Library Granted Patent US 7,049,118
Granted Patent B2
US 7,049,118 · App. 10/451,375 · Granted May 23, 2006

Regulation of human serine-threonine protein kinase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,118
App. No.
10/451,375
Granted
May 23, 2006
Kind
B2
Abstract

Reagents that regulate human serine-threonine protein kinase and reagents which bind to human serine-threonine protein kinase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, diabetes, COPD, and peripheral and central nervous system disorders.

Claims (25)

1. An isolated and purified protein comprising a first polypeptide segment comprising an amino acid sequence shown in SEQ ID NO:6.

2. The protein of claim 1 further comprising a second polypeptide segment comprising an amino acid sequence which is not an amino acid sequence shown in SEQ ID NO:6, wherein the second polypeptide segment is joined to the first polypeptide segment by means of a peptide bond.

3. An isolated and purified polynucleotide which encodes an amino acid sequence shown in SEQ ID NO:6.

4. The polynucleotide of claim 3 which comprises a nucleotide sequence shown in SEQ ID NO:5.

5. The polynucleotide of claim 3 which is a cDNA.

6. An isolated single stranded polynucleotide sequence coding for SEQ ID NO:6, wherein the coding sequence comprises the nucleotide sequence shown in SEQ ID NO: 5.

7. An expression construct, comprising;

a coding sequence for an amino acid sequence shown in SEQ ID NO:6; and

a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence.

8. The expression construct of claim 7 wherein the coding sequence comprises a nucleotide sequence shown in SEQ ID NO:5.

9. A host cell comprising an expression construct, wherein the expression construct comprises:

a coding sequence for a protein comprising an amino acid sequence shown in SEQ ID NO:6; and

a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence.

10. The host cell of claim 9 which is prokaryotic.

11. The host cell of claim 9 which is eukaryotic.

12. A method of producing a protein, comprising the steps of:

culturing a host cell in a culture medium, wherein the host cell comprises an expression construct comprising (a) a coding sequence for a protein comprising an amino acid sequence shown in SEQ ID NO:6 and (b) a promoter which is located upstream from the coding sequence and which controls expression of the coding sequence, wherein the step of culturing is carried out under conditions whereby the protein is expressed; and

recovering the protein.

13. A composition comprising:

a protein comprising an amino acid sequence shown in SEQ ID NO:6; and

a pharmaceutically acceptable carrier.

14. A composition comprising:

a polynucleotide encoding a protein comprising an amino acid sequence shown in SEQ ID NO:6; and

a pharmaceutically acceptable carrier.

15. The composition of claim 14 wherein the polynucleotide comprises a nucleotide sequence shown in SEQ ID NO:5.

Assignments (3)
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2006
From: BAYER AKTIENGESELLSCHAFT
To: BAYER HEALTHCARE AG
Reel/Frame 017308/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2003
From: KOHLER, RAINER H.
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 014855/0983 →